Calley Means joins Dasha Burns at a Politico health care summit to discuss HHS Secretary Robert F. Kennedy Jr.'s MAHA agenda. In this portion, he calls out food industry lobbyists for influencing the ...

Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that left investors unimpressed.

Shaun T, who trains Lizzo, recently defended the singer against accusations that she's using the weight loss drug Ozempic.

Novo Nordisk saw its stock drop 21% year-to-date, pressured by weaker-than-expected obesity drug trial results.

A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...

Singer Meghan Trainor has finally confirmed what fans have been speculating about for months—her dramatic weight loss wasn’t ...

Questions about insurance coverage for weight-loss drugs are getting more intense as cheaper alternatives go off the market.

A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 ...

As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – ...

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and ...